Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, is set to launch HMH 24/7, an AI-driven solution designed to enhance primary care by seamlessly integrating virtual and in-person services. This initiative reflects Hackensack Meridian Health’s commitment to…
ImmunoPrecise Antibodies Ltd (IPA) (NASDAQ: IPA), a biotherapeutics research and technology company utilizing artificial intelligence, has reported its financial results for the first quarter of fiscal 2025, ending July 31, 2024. All figures are presented in Canadian dollars (CAD) unless…
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company specializing in liver-targeted cancer therapies, announced new subgroup analysis data from the FOCUS Phase 3 trial of HEPZATO KIT™ (melphalan/Hepatic Delivery System) in patients with metastatic uveal melanoma (mUM). The data…
Cellworks Group Inc., a leader in personalized therapy decision support and precision drug development, has announced promising results from a study using its computational biosimulation to predict immunotherapy (IO) responses in non-small cell lung cancer (NSCLC) patients. By combining biosimulation…
RevBio, Inc. has secured a $2.4 million Phase II SBIR grant from the National Institute of Neurological Disease and Stroke (NINDS), part of the NIH. The two-year grant will support a 20-patient pilot clinical trial to evaluate the safety and…
CVS Health® (NYSE: CVS) has announced that CVS Pharmacy® locations in Massachusetts are now offering hormonal contraceptive prescribing services. Patients seeking birth control can be evaluated by a CVS pharmacist and, if eligible, receive a prescription directly from the pharmacy.…
CareDx, Inc. (Nasdaq: CDNA), a leader in precision medicine for transplant patients, announced today that it granted restricted stock units (RSUs) totaling 44,000 shares to 14 new employees on September 12, 2024, as an inducement for joining the company. These…
Tempus AI, Inc. (NASDAQ: TEM), a leader in using AI for precision medicine, has announced that four of its abstracts have been accepted for the European Society for Medical Oncology (ESMO) Congress 2024. The event will take place in Barcelona,…
CDR-Life has announced key advancements in its M-gager® programs targeting solid tumors, highlighting notable progress in its mission to develop innovative antibody fragment-based immunotherapies for challenging cancers. First Patient Dosed with CDR404 CDR-Life has dosed its first patient with CDR404,…
Rising Pharmaceuticals, Inc. has announced the commercial launch of Edetate calcium disodium injection. Despite a current shortage of this product in the U.S., Rising’s version remains available. Rising Pharmaceuticals, Inc. has announced the availability of Edetate calcium disodium injection, which…
Masimo (NASDAQ: MASI), a leading innovator in medical technology, has announced a new partnership with Google to develop a reference platform for Wear OS by Google™ smartwatches. This collaboration will integrate Masimo’s advanced biosensing technologies, honed through decades of hospital…
SamanTree Medical, a pioneer in surgical imaging technology, has announced that its Histolog® Scanner has received FDA 510(k) clearance. This groundbreaking Swiss device offers real-time, high-resolution imaging of fresh tissue surfaces, enabling detailed visualization of internal microstructures such as cells,…